532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,224.00
arrow_downward
-1.17%(-26.30) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 532296...
Buksan
₹2,249.80
Mataas
₹2,264.00
Mababa
₹2,224.00
Mkt. cap
628.43B
Avg. na dami
17.97K
Dami
12.94K
Dividend
0.22%
Bawat tatlong buwang dividend
₹1.25
Petsa ng ex-dividend
Okt 3, 2025
P/E ratio
34.92
Mataas nang 52-wk
₹2,536.85
Mababa nang 52-wk
₹1,794.00
EPS
₹63.68
Mga natitirang share
0.00
Bilang ng mga empleyado
17K
Buksan
₹2,249.80
Mataas
₹2,264.00
Mababa
₹2,224.00
Mkt. cap
628.43B
Avg. na dami
17.97K
Dami
12.94K
Dividend
0.22%
Bawat tatlong buwang dividend
₹1.25
Petsa ng ex-dividend
Okt 3, 2025
P/E ratio
34.92
Mataas nang 52-wk
₹2,536.85
Mababa nang 52-wk
₹1,794.00
EPS
₹63.68
Mga natitirang share
0.00
Bilang ng mga empleyado
17K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
NDTV Profit
·
7 oras ang nakalipas
84 Percent Stocks In Correction, Yet S&P 500 Nears Record High: What's Behind The 'Bull-Bear' Market?
investingLive
·
23 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
Reuters
·
4 araw ang nakalipas
Nasdaq ends down as chipmakers fall and bank earnings roll in
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
Tungkol sa Glenmark Pharmaceuticals Ltd